SEC Form 4 · accession 0001415889-15-001067
Cocrystal Pharma, Inc. · COCP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary Wilcox
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Mar 25, 2015
Accepted (ET)
Mar 27, 2015 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412486
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 25, 2015 | P | 54,348 | $0.92 | A | 16,889,585 | D |
Table II — derivative securities
No Table II lines on this filing.